In an era where precision is paramount, IntellxxDNA is revolutionizing the way physicians approach healthcare decisions. Unlike traditional genomics tools that focus solely on pharmacogenomics, cancer genomics, or rare diseases, IntellxxDNA provides a comprehensive solution for managing multifactorial chronic conditions such as heart disease, diabetes, cognitive decline, mental health issues, and autism, among others. By enabling physicians to identify and address the root causes of diseases, IntellxxDNA not only improves prevention and treatment but also reduces the cost of healthcare.
What sets IntellxxDNA apart is its ability to make genomics truly actionable. IntellxxDNA empowers physicians to implement personalized, precise treatment plans by reporting on gene variants with well-understood functions and pairing them with targeted potential interventions, including diet, lifestyle modifications, supplements and medications. This innovative approach is already being utilized by top physicians across the US to enhance patient outcomes and satisfaction and is being utilized in three IRB-approved trials focused on improving outcomes in cognitive decline and children with complex illness.